Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

United States of America, New York


Purpose:

The purpose of this study is to determine if PI-88 is effective and safe in patients who have had surgery to remove primary liver cancer.


Study summary:

Primary liver cancer (hepatocellular carcinoma or HCC) is the fifth most common cancer worldwide. Surgery to remove the tumour remains the principal form of treatment for liver cancer, however recurrence of the disease after surgery is common and survival after recurrence is poor. At the moment there is no recommended standard treatment for HCC immediately after the tumour has been removed surgically. PI-88 is a new experimental drug which blocks the growth of new blood vessels in tumours to stop the tumour growing (starves it of food) and also stops tumour cells spreading. Previous experience with PI-88 has shown it has been well tolerated and has shown some benefit in delaying the time it takes for the hepatocellular carcinoma to reappear after surgery. The purpose of this study is to determine if PI-88 is effective and safe in patients who have had surgery to remove primary liver cancer.


Criteria:

Key Inclusion Criteria: - Histologically-proven primary hepatocellular carcinoma with curative resection performed in the 4 - 6 weeks prior to randomisation. - ECOG performance status 0 to 2 - Child Pugh classification A or B Key Exclusion Criteria: - Any evidence of tumour metastasis or co-existing malignant disease - Any prior recurrence of HCC or any liver resection prior to the most recent procedure - History of prior HCC therapy


NCT ID:

NCT00568308


Primary Contact:

Principal Investigator
Ronnie TP Poon, MD
University of Hong Kong, Queen Mary Hospital


Backup Contact:

N/A


Location Contact:

United States of America, New York
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.